Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 9-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 12)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
8-Feb-10 PriceTarget Research, Inc. N/A Alexza Pharmactcls has a current Overall Rating of D (Negative). 7 $25 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: ALEXZA PHARMACEU -- ALXA 1 $4 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: ALXA , ALTH , ARIA , CORX , DEPO , ISTA , PTIE , QCOR -- DRUGS 3 $4 View Abstract
4-Feb-10 Wright Reports N/A Wright Investors Service Comprehensive Report for Alexza Pharmaceuticals, Inc. 40 $65 View Abstract
2-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for ALXA: the economy's impact on ALXA's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
6-Jan-10 Global Markets Direct Global Markets Direct Alexza Pharmaceuticals, Inc. Financial and Strategic Analysis Review 37 $300 View Abstract
30-Mar-09 Pechala's Reports Lubomir Pechala ALEXZA PHARMACEUTICALS INC (ALXA=US) - REPORT FOR ACTIVE TRADERS 4 $25 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Industry Report for DRUGS 18 $49 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for ALXA 13 $25 View Abstract
28-Mar-09 Pechala's Reports Frantisek Pechala ALEXZA PHARMACEUTICALS INC (ALXA=US) 12-months forecast 1 $15 View Abstract
Next 2

Independent Reports (Showing 1 to 10 of 12)

Release
Date Contributor Author Title Pages Price More Info
8-Feb-10 PriceTarget Research, Inc. N/A Alexza Pharmactcls has a current Overall Rating of D (Negative). 7 $25 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: ALEXZA PHARMACEU -- ALXA 1 $4 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: ALXA , ALTH , ARIA , CORX , DEPO , ISTA , PTIE , QCOR -- DRUGS 3 $4 View Abstract
4-Feb-10 Wright Reports N/A Wright Investors Service Comprehensive Report for Alexza Pharmaceuticals, Inc. 40 $65 View Abstract
2-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for ALXA: the economy's impact on ALXA's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
6-Jan-10 Global Markets Direct Global Markets Direct Alexza Pharmaceuticals, Inc. Financial and Strategic Analysis Review 37 $300 View Abstract
30-Mar-09 Pechala's Reports Lubomir Pechala ALEXZA PHARMACEUTICALS INC (ALXA=US) - REPORT FOR ACTIVE TRADERS 4 $25 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Industry Report for DRUGS 18 $49 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for ALXA 13 $25 View Abstract
28-Mar-09 Pechala's Reports Frantisek Pechala ALEXZA PHARMACEUTICALS INC (ALXA=US) 12-months forecast 1 $15 View Abstract
Next 2

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.